Organic Letters
Letter
(13) See ref 6a.
(14) The following substrates failed to afford significant amounts
(>10% by UPLC) of the desired carbonylation product under these
conditions: 4-methoxyphenyl tosylate, 2,4-dimethylphenyl tosylate, and
pyridin-3-yl tosylate.
AUTHOR INFORMATION
Corresponding Authors
■
(15) (a) Wan, Y.; Alterman, M.; Larhed, M.; Hallberg, A. J. Org. Chem.
2002, 67, 6232. (b) The only byproducts observed in these reactions,
besides unreacted starting aryl tosylates, were the products of reduction
of the aryl tosylates Ar-OTs to the hydrocarbons Ar-H. These reduction
products were not observed in every reaction, and were thought to likely
be due to reduction of the Pd(II) oxidative addition product by
dimethylamine, which was in turn derived by a competing side reaction
between tert-butylamine and DMF. This was confirmed by a blank
experiment, in which tert-butylamine and excess DMF were heated for
18 h at 100 °C under 60 psi of carbon monoxide pressure, that returned a
10% yield of tert-butylformamide, identified by comparison to an
authentic sample. The formation of reduction products could be largely
suppressed by substitution of DMA for DMF.
(16) Magerlein, W.; Indolese, A. F.; Beller, M. J. Organomet. Chem.
2002, 641, 30.
(17) For a review, see: Beletskaya, I. P.; Cheprakov, A. V. Chem. Rev.
2000, 100, 3009.
(18) This reaction was conducted without an added amine component.
(19) (a) Hermange, P.; Lindhardt, A. T.; Taanin, R. H.; Bjerglund, K.;
Lupp, D.; Skrydstrup, T. J. Am. Chem. Soc. 2011, 133, 6061.
(b) Marosvolgyi-Hasko, D.; Takacs, A.; Riedl, Z.; Kollar, L. Tetrahedron
2011, 67, 1036.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We gratefully acknowledge lively discussions with our colleagues
in the Pfizer “Palladium Club”.
REFERENCES
■
(1) For recent reviews, see: (a) Gadge, S. T.; Bhanage, B. M. RSC Adv.
2014, 4, 10367. (b) Fang, W.; Zhu, H.; Deng, Q.; Liu, S.; Liu, X.; Shen,
Y.; Tu, T. Synthesis 2014, 46, 1689. (c) Grigg, R.; Mutton, S. P.
Tetrahedron 2010, 66, 5515. (d) Brennfuhrer, A.; Neumann, H.; Beller,
M. Angew. Chem., Int. Ed. 2009, 48, 4114. (e) Skoda-Foldes, R.; Kollar, L.
Curr. Org. Chem. 2002, 6, 1097. (f) Wu, X.-F.; Neumann, H.; Beller, M.
Chem.Eur. J. 2010, 16, 9750.
(2) (a) Cacchi, S.; Ciattini, P. G.; Morera, E.; Ortar, G. Tetrahedron
Lett. 1986, 27, 3931. (b) Holt, D. A.; Levy, M. A.; Ladd, D. L.; Oh, H. J.;
Erb, J. M.; Heaslip, J. I.; Brandt, M.; Metcalf, B. W. J. Med. Chem. 1990,
33, 937. (c) Gerlach, U.; Wollmann, T. Tetrahedron Lett. 1992, 33, 5499.
(3) Key, B. D.; Howell, R. D.; Criddle, C. S. Environ. Sci. Technol. 1998,
32, 2283.
(4) (a) Kobayashi, Y.; Mizojiri, R. Tetrahedron Lett. 1996, 37, 8531.
(b) Ueda, M.; Saitoh, A.; Oh-tani, S.; Miyaura, N. Tetrahedron 1998, 54,
13079. (c) Percec, V.; Bae, J.-Y.; Hill, D. H. J. Org. Chem. 1995, 60, 1060.
(d) Percec, V.; Bae, J.-Y.; Zhao, M.; Hill, D. H. J. Org. Chem. 1995, 60,
1066.
(5) See, for example: Wilden, J. D.; Geldeard, L.; Lee, C. C.; Judd, D.
B.; Caddick, S. Chem. Commun. 2007, 1074.
(6) (a) Munday, R. H.; Martinelli, J. R.; Buchwald, S. L. J. Am. Chem.
Soc. 2008, 130, 2754. (b) Cai, C.; Rivera, N. R.; Balsells, J.; Sidler, R. R.;
McWilliams, J. C.; Schultz, C. S.; Sun, Y. Org. Lett. 2006, 8, 5161.
(c) Kubota, Y.; Nakada, S.; Sugi, Y. Synlett 1998, 183.
(7) Reeves, D. C.; Rodriguez, S.; Lee, H.; Haddad, N.; Krishnamurthy,
D.; Senanayake, C. H. Org. Lett. 2011, 13, 2495.
(8) (a) Odell, L. R.; Savmarker, J.; Larhed, M. Tetrahedron Lett. 2008,
̈
49, 6115. (b) For a nickel-catalyzed amidation of aryl tosylates by
isocyanates, see: Correa, A.; Martin, A. J. Am. Chem. Soc. 2014, 136,
7253. (c) For the synthesis of (2-alkoxy)aryl carboxamides from the
corresponding aryl iodides, see: Takac
́
s, A.; Abreu, A. R.; Peixoto, A. F.;
Pereira, M.; Kollar, L. Synth. Commun. 2009, 39, 1534.
́
(9) Sach, N. W. Abstracts of Papers, 244th ACS National Meeting &
Exposition, Philadelphia, PA, Aug 19−23, 2012; American Chemical
Society: Washington, DC, 2012.
(10) The conversion of tert-butyl amides to primary amides with TFA
has been reported; see, for example: (a) Wu, X.; Wan, Y.; Mahalingam,
́
A. K.; Murugaiah, A. M. S.; Plouffe, B.; Botros, M.; Karlen, A.; Hallberg,
M.; Gallo-Payet, N.; Alterman, M. J. Med. Chem. 2006, 49, 7160.
(b) Moree, W. J.; van der Marel, G. A.; Liskamp, R. J. J. Org. Chem. 1995,
60, 5157.
(11) The conversion of tert-butyl amides to nitriles has been reported;
see, for example: (a) With POCl3: Piwinski, J. J.; Wong, J. K.; Green, M.
J.; Ganguly, A. K.; Billah, M. M.; West, R. E., Jr.; Kreutner, W. J. Med.
Chem. 1991, 34, 457. (b) With PCl5: Carney, S. L.; Broadmore, R. J.;
Tomlinson, R.; Kingston, A.; Gallagher, P. T.; Owton, W. M.; Miles, M.
V.; Brunavs, M.; Smith, C. W.; Hicks, T. A.; Dobson, D. R.; Steggles, D.
J.; Ambler, S. J.; Halliday, K. A. Bioorg. Med. Chem. Lett. 1997, 7, 817.
(12) These ligands are commercially available as their HBF4 salts. We
found that these ligands purchased as the free phosphines were of
unreliable purity.
D
Org. Lett. XXXX, XXX, XXX−XXX